Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: Correlation with repair

NMR in Biomedicine

Volumn 11, Issue 1, 1998, Pages 1-10

  McIntosh, Laura ^a   Granberg, Karl Erik ^a   Brière, Kathleen M ^b   Anderson, Judy E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

1H NMR; Deflazacort; Glucocorticoids; Mdx mouse; Muscle regeneration; Muscular dystrophy; Prednisone; Proton nuclear magnetic resonance

Indexed keywords

CREATINE; DEFLAZACORT; GLUCOCORTICOID; LIPID; METHYLCELLULOSE; PLACEBO; PREDNISONE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DUCHENNE MUSCULAR DYSTROPHY; MOUSE; MUSCLE GROWTH; MUSCLE REGENERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; DISCRIMINANT ANALYSIS; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PHENOTYPE; PREDNISONE; PREGNENEDIONES; REGENERATION;

ANIMALIA;

EID: 0031970645     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199802)11:1<1::AID-NBM493>3.0.CO;2-D     Document Type: Article

References (45)

1. Bieber F. R. and Hoffman E. P. Duchenne and Becker muscular dystrophies: genetics, prenatal diagnosis, and future prospects. Clin. Perinatol. 17, 845-865 (1990).
2. Partridge T. A. Pathophysiology of muscular dystrophy. Br. J. Hosp. Med. 49, 26-36 (1993).
3. Matsumura K. and Campbell K. P. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17, 2-15 (1994).
4. Mizuno Y., Yoshida M., Nonaka I., Hirai S. and Ozawa E. Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy. Muscle Nerve 17, 206-216 (1994).
5. Karpati G. and Acsadi G. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases. Muscle Nerve 16, 1141-1153 (1993).
6. Fenichel G. M., Florence J. M., Pestronk A., Mendell J. R., Moxley R. T. and Griggs R. C. et al. Long-term benefits from prednisone therapy in Duchenne muscular dystrophy. Neurol. 41, 1874-1877 (1991).
7. Khan M. A. Corticosteroid therapy in Duchenne muscular dystrophy. J. Neurol. Sci. 120, 8-14 (1993).
8. Metzinger L., Passaquin A. C., Water J. M. and Poindron P. α-Methylprednisolone promotes skeletal myogenesis in dystrophin-deficient and control mouse cultures. Neurosci. Lett. 155, 171-174 (1993).
9. Passaquin A. C., Metzinger L , Léger J. J., Warter J. M. and Poindron P. Prednisolone enhances myogenesis and dystrophin-related protein in skeletal muscle cell cultures from mdx mouse. J. Neurosci. Res. 35, 363-372 (1993).
10. Mesa L. E., Dubrovsky A. L., Corderi J., Marco P. and Flores D. Steroids in Duchenni muscular dystophy - Deflazacort trial. Neuromusc. Dis. 1, 261-266 (1991).
11. Angelini C., Pegoraro E., Turella E., Intino M. T., Pini A and Costa C. Deflazacort in Duchenne dytrophy: study of long-term effect. Muscle Nerve 17, 386-391 (1994).
12. Bulfield G., Siller W., Wight P. and Moore K. X-chromosome linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81, 1189-1192 (1984).
13. Anderson J. E., Ovalle W. K. and Bressler B. H. Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse. Anat. Rec. 219, 243-257 (1987).
14. Anderson J. E., Bressler B. H. and Ovalle W. K. Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J. Muscle Res. Cell Motil. 9, 499-516 (1988).
15. Stedman H. H., Sweeney H. L., Shrager J. B., Maguire H. C., Panettieri R. A., Petrof B., Narusawa M., Leferovich J. M., Sladky J. T. and Kelly A. M. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536-538 (1991).
16. Dupont-Versteegden E. E. and McCarter R. J. Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve 15, 1105-1110 (1992).
17. Anderson J. E., McIntosh L. M. and Poettcker R. Deflazacort but not prednisone improves muscle repair and fiber growth in diaphragm and limb muscles in vivo in the mdx mouse. Muscle Nerve 19, 1576-1585 (1996).
18. 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn. Reson. Med. 24, 123-136 (1992).
19. Heinriksen O. MR spectroscopy in clinical research. Acta Radiologica 35, 96-116 (1994).
20. 1H NMR visible lipids in colon tissue from normal and carcinogen-treated rats. NMR Biomed. 8, 33-40 (1995).
21. 1H NMR spectrum of a human glioma line. Magn. Reson. Imag. 12, 945-950 (1994).
22. 1H NMR spectroscopy in vivo. Magn. Reson. Med. 10, 210-226 (1989).
23. 1H spectroscopy of human skeletal muscle: normal and pathological findings. Magn. Reson. Imag. 10, 957-964 (1992).
24. Schick F., Eismann B., Jung W. I., Bongers H., Bunse M. and Lutz O. Comparison of loclized proton NMR signals of skeletal muscle and fat tissuein vivo: Two lipid compartments in muscle tissue. Magn. Reson. Med. 29, 158-167 (1993).
25. 1H NMR of mdx mouse muscle and myoblast cells during fusion: evidence for a characteristic signal of long chain fatty acids. Neuromusc. Disord. 3, 433-438 (1993).
26. McIntosh L. M., Pernitsky A. P. and Anderson J. E. The effects of altered metabolism (hypothyroidism) on muscle repair in themdx dystrophic mouse. Muscle Nerve 17, 444-453 (1994).
27. Kuesel A. C., Kroft T., Saunders J. K., Préfontaine M., Mikhael N. and Smith I. C. P. A simple procedure for obtaining high-quality NMR spectra of semiquanitative value from small tissue specimens: cervical biopsies. Magn. Reson. Med. 27, 349-355 (1992).
28. Williams S. R., Gadian D. G., Proctor E., Sprague D. B. and Talbot D. F. Proton NMR studies of muscle metabolism in vivo. J. Magn. Reson. 63, 406-412 (1985).
29. 1H NMR spectroscopy of colon tumors and normal mucosal biopsies; Elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance. NMR Biomed. 6, 111-118 (1993).
30. Shaw R. A., Mantsch H. and Anderson J. E. Infrared spectroscopy of dystrophic mdx mouse muscle tissue distinguishes among treatment groups. J. Appl. Physiol. 81, 2328-2335 (1996).
31. Nikulin A., Brière K. M., Friesen L., Smith I. C. P. and Somorjai R. L. Genetic algorithm-guided optimal attribute selection: a novel preprocessor for classifying magnetic resonance spectra. Proc. Soc. Magn. Reson. 3, 1940 (1995).
32. Chesney R. W. and Taurine: Its biological role and clinical implications. Adv. Pediat. 32, 1-42 (1985).
33. Wright C. E., Tallan H. H. and Yong Y. L. Taurine: biological update. Ann. Rev. Biochem. 55, 427-453 (1986).
34. Huxtable R. J. Physiological actions of taurine. Physiol. Rev. 72, 101-163 (1992).
35. Dangain J. and Vrbova G. Muscle development in mdx mutant mice. Muscle Nerve 7, 700-704 (1984).
36. Zacharias J. M. and Anderson J. E. Muscle regeneration after imposed injury is better in younger than older mdx dystrophic mice. J. Neurol. Sci. 104, 190-196 (1991).
37. DeLuca A., Camerino D. C., Failli P., Franconi F. and Giotti A. Effects of taurine on mammalian skeletal muscle fibers during development. Prog. Clin. Biol. Res. 351, 163-173 (1990).
38. Louboutin J. P., Fichter-Gagnepain V., Pastoret C., Thaon E., Noireaud J., Sebille A. and Fardeau M. Morphological and functional study of extensor digitorum longus muscle regeneration after iterative crush lesions in mdx mouse. Neuromusc. Disord. 5, 489-500 (1995).
39. Pernitsky A. P., McIntosh L. M. and Anderson J. E. Hyperthyroidism impairs early repair in normal but not dystrophic mdx mouse tibialis anterior muscle. An in vivo study. Biochem. Cell Biol. 74, 315-324 (1996).
40. Yoshizaki K., Seo Y. and Nishikawa H. High-resolution proton magnetic resonance spectra of muscle. Biochim. Biophys. Acta 678, 283-291 (1981).
41. May G. L., Wright L. C., Holmes K. T., Williams P. G., Smith I. C. P., Wright P. E., Fox R. M. and Mountford C. E. Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. J. Biol. Chem. 261, 3048-3053 (1986).
42. Mountford C. E. and Wright L. C. Organization of lipids in the plasma membranes of malignant and stimulated cells: a new model. TIBS 13, 172-177 (1988).
43. 1H-NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magn. Reson. Med. 29, 546-550 (1993).
44. Karpati G., Carpenter S. and Prescott S. Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11, 795-803 (1988).
45. McIntosh L. M. and Anderson J. E. Hypothyroidism prolongs and increases mdx muscle precursor proliferation and delays myotube formation in normal and dystrophic limb muscle. Biochem. Cell Biol. 73, 181-190 (1995).